栄研化学(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4549/E00961 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/01/25 | 日証協 | 53,400株 | +20.27% | 48,900株 | +190.22% | 96,753株 | -1.92% | 7,500株 | +519.83% |
| 2013/01/18 | 日証協 | 44,400株 | -0.22% | 16,849株 | +240.32% | 98,643株 | -2.45% | 1,210株 | -79.17% |
| 2013/01/11 | 日証協 | 44,500株 | -0.89% | 4,951株 | +312.58% | 101,125株 | +3.69% | 5,808株 | +2804% |
| 2013/01/04 | 日証協 | 44,900株 | -2.81% | 1,200株 | -94.91% | 97,525株 | +0.1% | 200株 | -90.48% |
| 2012/12/28 | 日証協 | 46,200株 | -1.72% | 23,559株 | +3.46% | 97,425株 | +0.62% | 2,100株 | +75% |
| 2012/12/21 | 日証協 | 47,010株 | -19.24% | 22,771株 | +4.64% | 96,826株 | -10.03% | 1,200株 | -81.54% |
| 2012/12/14 | 日証協 | 58,210株 | -14.45% | 21,761株 | -46.76% | 107,626株 | -8.3% | 6,500株 | -85.16% |
| 2012/12/07 | 日証協 | 68,045株 | -17.57% | 40,871株 | -20.82% | 117,362株 | -15.91% | 43,801株 | -14.77% |
| 2012/11/30 | 日証協 | 82,545株 | +15.23% | 51,618株 | +89.08% | 139,561株 | +15.29% | 51,390株 | +505.3% |
| 2012/11/22 | 日証協 | 71,635株 | -5.29% | 27,300株 | -29.18% | 121,052株 | -0.42% | 8,490株 | +107.07% |
| 2012/11/16 | 日証協 | 75,635株 | +4.19% | 38,551株 | +10.58% | 121,562株 | -0.25% | 4,100株 | -10.87% |
| 2012/11/09 | 日証協 | 72,596株 | +5.28% | 34,861株 | -7.94% | 121,862株 | -9.17% | 4,600株 | -66.07% |
| 2012/11/02 | 日証協 | 68,955株 | -6.03% | 37,867株 | -37.63% | 134,172株 | -11.61% | 13,556株 | -19.19% |
| 2012/10/26 | 日証協 | 73,381株 | -12.67% | 60,716株 | +9.27% | 151,788株 | -1.31% | 16,776株 | -27.86% |
| 2012/10/19 | 日証協 | 84,024株 | -10.02% | 55,566株 | +43.02% | 153,799株 | +7.74% | 23,255株 | +8.45% |
| 2012/10/12 | 日証協 | 93,380株 | +2.86% | 38,851株 | -27.25% | 142,755株 | +2.36% | 21,443株 | -6.88% |
| 2012/10/05 | 日証協 | 90,783株 | -20.41% | 53,407株 | -0.88% | 139,458株 | -2.84% | 23,027株 | +87.1% |
| 2012/09/28 | 日証協 | 114,062株 | +5.01% | 53,883株 | +136.03% | 143,530株 | -4.5% | 12,307株 | -71.19% |
| 2012/09/21 | 日証協 | 108,619株 | -6.25% | 22,829株 | +15.71% | 150,294株 | -4.78% | 42,713株 | -24.92% |
※株式分割は考慮していませんのでご注意ください。
Page Top